- Home
- TYGO vs XTNT Comparison
TYGO vs XTNT Comparison
Compare TYGO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- XTNT
- Stock Information
- Founded
- TYGO 2007
- XTNT N/A
- Country
- TYGO United States
- XTNT United States
- Employees
- TYGO N/A
- XTNT N/A
- Industry
- TYGO Semiconductors
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TYGO Technology
- XTNT Health Care
- Exchange
- TYGO Nasdaq
- XTNT Nasdaq
- Market Cap
- TYGO 53.5M
- XTNT 55.6M
- IPO Year
- TYGO N/A
- XTNT N/A
- Fundamental
- Price
- TYGO $0.87
- XTNT $0.37
- Analyst Decision
- TYGO Buy
- XTNT Strong Buy
- Analyst Count
- TYGO 3
- XTNT 1
- Target Price
- TYGO $3.00
- XTNT $3.00
- AVG Volume (30 Days)
- TYGO 31.8K
- XTNT 226.3K
- Earning Date
- TYGO 02-11-2025
- XTNT 11-12-2024
- Dividend Yield
- TYGO N/A
- XTNT N/A
- EPS Growth
- TYGO N/A
- XTNT N/A
- EPS
- TYGO N/A
- XTNT N/A
- Revenue
- TYGO $45,985,000.00
- XTNT $113,862,000.00
- Revenue This Year
- TYGO N/A
- XTNT $31.82
- Revenue Next Year
- TYGO $57.24
- XTNT $13.64
- P/E Ratio
- TYGO N/A
- XTNT N/A
- Revenue Growth
- TYGO N/A
- XTNT 45.11
- 52 Week Low
- TYGO $0.78
- XTNT $0.33
- 52 Week High
- TYGO $2.19
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- TYGO 45.52
- XTNT 29.03
- Support Level
- TYGO $0.86
- XTNT $0.33
- Resistance Level
- TYGO $0.99
- XTNT $0.39
- Average True Range (ATR)
- TYGO 0.07
- XTNT 0.02
- MACD
- TYGO 0.02
- XTNT 0.00
- Stochastic Oscillator
- TYGO 62.79
- XTNT 46.78
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.